Omar Lopez Ocejo

Title: Omar Lopez Ocejo: Innovator in Active Antiangiogenic Therapy

Introduction

Omar Lopez Ocejo is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of medical therapies, particularly in the area of active antiangiogenic therapy. With a total of 2 patents, his work focuses on innovative approaches to combat various diseases associated with angiogenesis.

Latest Patents

Omar Lopez Ocejo's latest patents include groundbreaking applications of oligonucleotide and polypeptide sequences derived from the vascular permeability factor (VPF) and its receptors. These patents detail methods for utilizing these sequences in active immunotherapy for conditions where increased angiogenesis is a factor. His innovative procedures can be employed in both single and combined therapies for treating cancer and its metastasis, as well as a range of other health issues, including acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma.

Career Highlights

Throughout his career, Omar Lopez Ocejo has worked with esteemed organizations such as the Centro de Ingeniería Genética y Biotecnología. His experience in these institutions has allowed him to develop and refine his innovative therapeutic approaches.

Collaborations

Omar has collaborated with notable colleagues, including Mónica Bequet Romero and Ricardo De La Caridad Silva Rodriguez. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Omar Lopez Ocejo stands out as a pioneering inventor in the field of active antiangiogenic therapy. His contributions have the potential to significantly impact the treatment of various diseases, showcasing the importance of innovation in medical science.